Reshape Lifesciences Inc. buy melinda
Start price
24.01.21
/
0%
€702.00
Target price
24.01.22
-
Performance (%)
-50.11%
End price
20.04.21
€350.25
Summary
This prediction ended on 20.04.21 with a price of €350.25. Massive losses of -50.11% were the result for the BUY prediction by melinda. This prediction was marked as speculative and is excluded from melinda's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Reshape Lifesciences Inc. | - | - | - | - |
| iShares Core DAX® | 0.160% | -1.640% | 12.016% | 15.557% |
| iShares Nasdaq 100 | -3.020% | -4.715% | 37.102% | 42.685% |
| iShares Nikkei 225® | -2.519% | -7.621% | 18.066% | 2.904% |
| iShares S&P 500 | -1.377% | -2.809% | 26.536% | 41.689% |
According to melinda what are the pros and cons of Reshape Lifesciences Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Obalon Therapeutics Inc. diskutieren
Buy Obalon Therapeutics Inc.
In the thread Trading Obalon Therapeutics Inc.
Stopped prediction by melinda for Reshape Lifesciences Inc.
Reshape Lifesciences Inc.
Start price
Target price
Perf. (%)
€350.25
20.04.21
20.04.21
€525.00
20.04.22
20.04.22
-85.52%
21.04.22
21.04.22
Could be worthwhile Investment >10% per year
